Vanguard Group Inc Exicure, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.37 - $0.75 $1,840 - $3,731
4,975 Added 14.17%
40,093 $23,000
Q3 2023

Nov 14, 2023
BUY
$0.71 - $1.36 $568 - $1,088
800 Added 2.33%
35,118 $25,000
Q1 2023

May 15, 2023
SELL
$0.78 - $1.58 $393 - $796
-504 Reduced 1.45%
34,318 $29,000
Q3 2022

Nov 14, 2022
SELL
$1.53 - $8.5 $85,126 - $472,923
-55,638 Reduced 61.51%
34,822 $55,000
Q2 2022

Aug 12, 2022
BUY
$2.16 - $6.36 $195,393 - $575,325
90,460 New
90,460 $195,000

Others Institutions Holding XCUR

# of Institutions
2
Shares Held
287K
Call Options Held
0
Put Options Held
0
View Full List

About EXICURE, INC.

XCUR Quotes by TradingView
  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $55.5M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email